How Startup Valuation Works at Seed and Pre-Seed

Early-stage startup valuation is not science. There are no cash flows to discount, no earnings multiples to apply. At pre-seed and seed, valuation is a negotiated estimate of what a company might be worth, based on a collection of signals and comparables.

Understanding the methods investors use — even informally — helps you negotiate from a position of knowledge.

Why Valuation Matters

Valuation at seed determines dilution. If you raise $1M at a $4M pre-money valuation, you're selling 20% of your company. If you raise the same $1M at a $9M cap (on a SAFE), your dilution depends on what your Series A is priced at.

Getting valuation wrong in either direction has consequences:

• Too low: You give away too much equity, constraining future fundraising and reducing your and your team's ownership
• Too high: You set a benchmark you can't hit, making your next round a down round — which has legal, psychological, and reputational costs

The Main Valuation Methods

Comparable Transactions (Comps)

The most common approach in practice. Investors look at what similar companies raised at, at similar stages, and use that as a reference point.

"A B2B SaaS company with $10K MRR raising in today's market is typically valued between $5M and $10M pre-money."

The problem: comparables are often invisible. Investors have more data than founders, because they see hundreds of deals. You can partially offset this by talking to other founders, reading VC annual reports, and tracking deal announcements on Crunchbase.

At seed, the market does most of the work. Learn what's normal for your stage, sector, and geography before negotiating.

The Berkus Method

Developed by angel investor Dave Berkus for pre-revenue companies. It assigns a maximum value to five risk dimensions:

| Factor | Maximum Value | |---|---| | Compelling idea (reduces product risk) | $500K | | Working prototype (reduces technology risk) | $500K | | Quality management team (reduces execution risk) | $500K | | Strategic relationships (reduces market risk) | $500K | | Product rollout or sales (reduces production risk) | $500K |

Maximum valuation: $2.5M pre-money. This was calibrated in a different era and for smaller check sizes — modern pre-seed rounds often far exceed this — but the framework is useful for identifying what investors are actually assessing.

Risk Factor Summation Method

Start with a base valuation (often a comparable company) and adjust it based on 12 risk factors:

• Management risk
• Stage of business risk
• Legislation/political risk
• Manufacturing risk
• Sales and marketing risk
• Funding and capital-raising risk
• Competition risk
• Technology risk
• Litigation risk
• International risk
• Reputation risk
• Potential lucrative exit risk

Each factor is scored from -2 (very high risk) to +2 (very low risk), and each point adjusts the base valuation by a set amount (e.g., $250K). This gives a more systematic but still subjective result.

In practice, most investors do this intuitively rather than on a spreadsheet.

Scorecard Method

Similar to risk factor summation. You benchmark against the average pre-money valuation for seed deals in your region and sector, then apply a multiplier based on:

• Strength of management team (0–30% weight)
• Size of opportunity (0–25% weight)
• Product/technology (0–15% weight)
• Competitive environment (0–10% weight)
• Marketing/sales/partnerships (0–10% weight)
• Need for additional investment (0–5% weight)
• Other factors (0–5% weight)

This is most commonly used by angel groups with formal processes.

How Dilution Works

If you raise $500K at a $2M pre-money valuation:

• Post-money valuation = $2M + $500K = $2.5M
• Investor ownership = $500K / $2.5M = 20%

With a SAFE (no priced round), dilution is calculated at conversion, typically at your Series A. A SAFE with a $5M cap means the investor converts as if the pre-money was $5M, regardless of what the Series A is actually priced at — if the Series A is priced above the cap.

What's Normal at Each Stage

These are approximate ranges for software/SaaS companies in established startup markets (US, UK, western Europe):

| Stage | Round Size | Pre-Money Valuation | |---|---|---| | Pre-seed (idea/MVP) | $150K–$1M | $1.5M–$6M | | Seed (early traction) | $1M–$4M | $5M–$15M | | Seed+ (growing revenue) | $2M–$6M | $10M–$25M | | Series A | $5M–$20M | $20M–$80M |

These vary significantly by sector, team pedigree, and market conditions. Companies with exceptional founder track records or breakthrough technology command premiums.

Practical Advice

Know your number before you negotiate. Research comparable deals. Talk to founders who raised recently. Come to the conversation with a range you can defend.

Optimize for the relationship, not the cap. A $6M cap with a great investor who adds real value often beats an $8M cap with a passive check-writer.

Don't anchor too high on your first round. A high seed valuation that you can't grow into creates serious problems at Series A. Flat rounds and down rounds are technically survivable but damaging in practice.

Use the SAFE cap to signal confidence. Your valuation cap is a statement about where you think the company will be at Series A. Be ambitious but realistic.